Search CCW

Clinical Studies in Children with Cancer

Our patients and their families have the opportunity to participate in clinical trials exploring the most promising treatments in CAM and integrative medicine, psychosocial support and survivor wellness. The following is a list of our open clinical trials, with contact information for enrollment.

 

Nutrition and Integrative Medicine

  • A prospective study evaluating the role of dietary intake and nutritional status on neuropathy, functional measures of quality of life, and fatigue in children receiving treatment for a brain tumor
    This longitudinal study will explore the relationship of compromised nutrition status, fatigue, and functional quality of life in children between the ages of 3 to 25 with a diagnosis of medulloblastoma, ependymoma, germinoma, high- or low-grade glioma, or craniopharyngioma. 
  • Cross-Sectional Survey Exploring Psychosocial Variables Associated with Diet and Exercise Behaviors During and After Treatment for a Pediatric Malignancy   
    The purpose of this study is to explore current lifestyle behaviors and relevant psychosocial mediators of diet and exercise behaviors to better understand the obstacles and barriers to adopting healthy lifestyle behaviors.  This study is open to patients between the ages of 12 and 25 who have recently received a cancer diagnosis, are in treatment for cancer, or have completed cancer treatment within the last year.

For information about enrollment, please contact Andrea Radossi at (646) 317-2070 or by email at ar3454@columbia.edu.

Psychosocial

  • Behavioral Activation Therapy   
    This 6-session cognitive behavioral therapeutic research intervention is available to adolescents who are experiencing significant symptoms of anxiety, depression or problems with adjusting to either their diagnosis and treatment or survivorship. 
  • Neurocognitive Functioning of ALL patients 
    Patients aged 5 years and older who are being treated on the Dana Farber 11-001 Leukemia treatment protocol are eligible for this study that examines their neurocognitive functioning over the course of treatment and survivorship.
  • Suncoast Studies 
    As the Principal Investigator at the Columbia University Medical Center for Suncoast Clinical Research focusing upon supportive care, we offer a range of studies including a 6-week randomized study examining the impact of the use of the medication Provigil to improve the attention-concentration of brain tumor survivors.
  • Heath Related Quality of Life (HRQoL)  
    Patients undergoing stem cell transplantation at Columbia University Medical Center are eligible to participate in this study that prospectively monitors their HRQoL beginning before transplantation and at multiple time points over the ensuing years.
  • Neurocognitive Functioning of Brain Tumor patients (ALTE07C1)  
    Pediatric patients being treated through the Children’s Oncology Group (COG) for brain tumors are eligible for this study that examines their neurocognitive functioning over the course of treatment and survivorship.

For information about enrollment, please contact Mirko Savone at (212) 305-4030, or by email at ms4750@columbia.edu.

Survivor Wellness

 

For information about enrollment, please contact Trisha Ali-Shaw at (212) 305-2354 or by email at ta2378@columbia.edu.